- Home
- Labeler Index
- Catalent Indiana, Llc
- 61434-018
- NDC Crossover: 61434-018 Benralizumab
NDC Crossover 61434-018 Benralizumab
View and Compare Similar Products, Alternatives & Options
NDC Crossover of Similar Products Matching Benralizumab
The Similar Products in this help users find alternative medications and related products based on key similarities in their regulatory status, product name, active ingredients, dosage form, and administration route.
Explore similar products to 61434-018 – Benralizumab, a human prescription drug. This list includes other cross-matching products that share:
- The same product name: Benralizumab
- OR Generic name: Benralizumab
- AND the same Administration Route:
- OR Dosage Form: injection, solution
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
---|---|---|---|---|---|---|
0310-1730 | Fasenra | Benralizumab | Injection, Solution | Subcutaneous | Astrazeneca Pharmaceuticals Lp | Human Prescription Drug |
0310-1745 | Fasenra | Benralizumab | Injection, Solution | Subcutaneous | Astrazeneca Pharmaceuticals Lp | Human Prescription Drug |
0310-1830 | Fasenra | Benralizumab | Injection, Solution | Subcutaneous | Astrazeneca Pharmaceuticals Lp | Human Prescription Drug |